Benitec Biopharma (BNTC) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

BNTC Benitec Biopharma

Watchlist

10.5100
-0.0500-0.47%

Close Oct 31 16:00 ET

10.5100
0.00000.00%

Post 16:01 ET

208.26MMarket Cap-1907P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Benitec Biopharma (BNTC) Receives a Buy From Piper Sandler
TipRanksOct 18 06:36 ET · Ratings
Oppenheimer Maintains Benitec Biopharma(BNTC.US) With Buy Rating, Maintains Target Price $35
Moomoo NewsOct 16 08:31 ET · Ratings
Oppenheimer Initiates Benitec Biopharma(BNTC.US) With Buy Rating, Announces Target Price $35
Moomoo NewsOct 15 16:31 ET · Ratings
Benitec Biopharma Initiated With an Outperform at Oppenheimer
TipRanksOct 15 16:11 ET · Ratings
Benitec Biopharma Participates in a Conference Call With Piper Sandler
TipRanksOct 15 15:45 ET
Benitec Biopharma Reports Promising Results for BB-301 Trial
TipRanksOct 15 08:30 ET

Comments

HugoV

Oct 17 12:52

👀

$Benitec Biopharma (BNTC.US)$

Jaguar8

Oct 13 20:57

WEEKEND NEWS (Sat)

$Benitec Biopharma (BNTC.US)$
Benitec Biopharma Reports Positive Data from Two Subjects Treated with Low-Dose BB-301 in Phase 1b/2a Study Presented at 29th Annual Congress of the World Muscle Society
Benitec Biopharma (NASDAQ: BNTC) reported positive interim data from its Phase 1b/2a study of BB-301 for Oculopharyngeal Muscular Dystrophy (OPMD). Two subjects treated with the low-dose BB-301 showed durable, clinically meaningful improvements in swallowing at 9 and 6 months post-t...

Stock_Drift

Oct 12 07:08

Benitec Biopharma:

$Benitec Biopharma (BNTC.US)$

Trytosaveabit

Apr 18 06:35

News

$Benitec Biopharma (BNTC.US)$ Benitec Biopharma Inc: Bb-301 Has Been Granted Orphan Drug Designation by US FDA and EMA Committee for Orphan Medicinal Products (Comp)